2022

• Just released National Medicines Policy sets high ambitions for better health outcomes for all Australians Tuesday, 20 December 2022
• New report indicates COVID-19 vaccines saved Australia’s economy Monday, 19 December 2022
• Landmark event advances horizon scanning for disruptive health technologies in Australia Tuesday, 6 December 2022
• New Translational Science Hub in Queensland to boost Australia’s biomedical capacity and capability and deliver faster access to mRNA innovations Monday, 5 December 2022
• Medicines industry calls for discount rate reduction now Friday, 18 November 2022
• New Horizons event, to explore the exciting medicines of tomorrow Monday, 14 November 2022
• Summit brings together medicines industry, academia and patient groups ahead of health reform Friday, 11 November 2022
• Medicines Australia welcomes new Board members Friday, 4 November 2022
• Independent Chair of Health Technology Assessment (HTA) Review will drive major reform of Australia’s health system Thursday, 27 October 2022
• October Budget 2022-23: A no surprise budget for health Tuesday, 25 October 2022
• Australian pharmaceutical industry representative group launches report on future of workplace inclusion Thursday, 13 October 2022
• COVID-19 vaccine procurement review says rapid access to vaccines and treatments key to ongoing protection of Australians Tuesday, 27 September 2022
• National Medicines Policy draft strides ahead but still room for improvement Monday, 26 September 2022
• Vale William Delaat AM Thursday, 15 September 2022
• Innovative medicines showcase will demonstrate the power of partnership at Parliament House next week Wednesday, 7 September 2022
• Parliament House event to shine a spotlight on the future of innovative medicines Wednesday, 31 August 2022
• Restart of National Medicines Policy Review is welcome, but assurances needed over further consultation and feedback processes Thursday, 18 August 2022
• Medicines Australia receives two awards for exemplary workplace culture Tuesday, 9 August 2022
• Medicines Australia appoints Gail Morgan as new Head of Government Relations Tuesday, 2 August 2022
• Medicines industry working to minimise medicine supply shortages Friday, 22 July 2022
• IP waiver for COVID vaccines is a threat to future innovation Monday, 20 June 2022
• IP waiver for COVID vaccines misses the mark in vaccinating the world Tuesday, 14 June 2022
• Medicines Australia moves quickly to put HTA system reform high on new Government’s agenda Friday, 10 June 2022
• Medicines Australia congratulates new shadow ministry appointments Tuesday, 7 June 2022
• New Health Minister Mark Butler can lead generational health reform for all Australians Tuesday, 31 May 2022
• Medicines Australia welcomes new leaders of the Liberal and National Parties Tuesday, 31 May 2022
• Medicines Australia ready to work with new Government on medicines reform and life sciences Monday, 23 May 2022
• Medicines Australia puts spotlight on reform priority for the next Government Friday, 20 May 2022
• Major parties committed to major medicines policy reform and reviews – whoever wins on Saturday Thursday, 19 May 2022
• Discount rate adjustment for the health of future generations Tuesday, 17 May 2022
• Next Health Minister must restart the National Medicines Policy Review Tuesday, 10 May 2022
• Award winners recognised in pharmaceutical industry education course Wednesday, 4 May 2022
• Transcript: ABC Radio Adelaide on the PBS co-payment Tuesday, 3 May 2022
• What is the HTA Review and why is it important for Australia’s health system? Tuesday, 3 May 2022
• Affordable medicines just the tip of the iceberg for equitable access for all Australians Monday, 2 May 2022
• Health consumer leader built strong partnerships across the health sector Wednesday, 27 April 2022
• Patient voice and experience must be part of the Government’s decision-making when funding medicines Wednesday, 27 April 2022
• Making #MedicinesMatter for all Australians Thursday, 21 April 2022
• Big challenges ahead for new Health Minister designate Sunday, 17 April 2022
• Faster patient access to new medicines must be a priority for next Government Sunday, 10 April 2022
• Health Technology Assessment (HTA) Review Reference Committee will drive reform to support Australian patients Sunday, 10 April 2022
• Budget 2022-23 – No ‘big bang’ announcements in Health Tuesday, 29 March 2022
• Medicines Australia acknowledges Senator Kim Carr’s contribution to industry and innovation Tuesday, 29 March 2022
• Federal Budget vision must extend beyond election day to secure better long-term health for all Australians Monday, 28 March 2022
• Leaked TRIPS proposal misguided about improving global COVID-19 vaccination rates Thursday, 24 March 2022
• Government opts for additional consultation on National Medicines Policy (NMP) Review Thursday, 24 March 2022
• New Australian agency to accelerate genomic research and drive innovation in healthcare Monday, 21 March 2022
• Australian cancer patients to get improved access to clinical trials Thursday, 17 March 2022
• Medicines Australia welcomes reform efforts to speed up clinical trials Friday, 4 March 2022
• MAP offers new online pathway for accessing cancer treatments Friday, 25 February 2022
• COVID-19 pandemic sends clear message that Australia must value the long-term health of all Australians Monday, 21 February 2022
• Patent box legislation to promote Australian innovation Friday, 11 February 2022
• National Medicines Policy too important to be rushed before Federal Election Thursday, 10 February 2022
• Medicines Australia calls for new National Medicines Policy (NMP) to be pushed back until after the Federal Election Friday, 4 February 2022
• Four new Board Directors announced for Medicines Australia Thursday, 3 February 2022
• Australians deserve fast access to the latest medicines, vaccines and treatments Friday, 28 January 2022
• Statement on the arrival of the Novavax vaccine and COVID-19 pills Thursday, 20 January 2022